First animal study in India on COVID-19 moves to final stage | DocMode
Select Page
First animal study in India on COVID-19 moves to final stage

A joint effort between the Ministry of Ayush and the Department of Bio-Technology (DBT), the first animal study in India on COVID-19, has progressed to its final level. This concerns pre-clinical studies on four oral therapies, according to the Ministry, which has already been taken up for clinical studies. In the Covid-19 context, it identified the study as one of the most sophisticated research projects in the world. The clinical studies are being carried out through another partnership between the Ministry of AYUSH and the Council for Scientific and Industrial Research, the partner in this one (CSIR).

The animal research partnership (in-vivo) emerged from an MoU signed between the Ministry of AYUSH’s National Medicinal Plants Board (NMPB) and the DBT. The Ministry said in a statement that it is based on the idea of reverse pharmacology (PH), which discusses the scientific rationale behind existing medical practices such as Ayurveda.

The study was performed at the Faridabad-based Translational Health Science and Technology Institute (THSTI), an autonomous DBT institute. These experiments, held on hamsters, were housed in the sophisticated BSL-3 level laboratories of THSTI. “This is a proud moment for both the Ministry of Ayush and the Biotechnology Department that this collaboration is leading to research on landmarks in India,” said Vaidya Rajesh Kotecha, Secretary of the Ayush Ministry.

Tag Cloud

Follow us on Facebook

Follow us on Twitter